Open AccessFCX, an arylidene derivative, induces apoptosis in androgen receptor-selective prostate cancer cells
Author(s) -
Prasanna Rajagopalan,
Ashraf A. El-Bessoumy,
Harish C. Chandramoorthy,
Ayed A. Dera,
Majed Al Fayi
Publication year - 2021
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/jcrt.jcrt_228_17
Subject(s) - lncap , chemistry , androgen receptor , prostate cancer , cell growth , propidium iodide , cell cycle , apoptosis , cancer research , dna fragmentation , mtt assay , medicine , biology , cancer , programmed cell death , biochemistry
Rational screening of arylidene derivatives for biological activities has resulted in many lead molecules with anticancer properties with effective therapeutic window.